宫内暴露抗疟药儿童眼部异常风险的系统综述
该系统综述检索PubMed、Embase和Web of Science至2017年3月,纳入10项队列研究、2项随机对照试验和3例病例报告,共1477名婴儿,其中789名暴露于羟氯喹或氯喹。综述提示产前暴露抗疟药的子代视觉异常风险低至不存在,但应避免高剂量。
要点
- 宫内暴露羟氯喹或氯喹的儿童眼部毒性风险低至不存在。
- SLE妊娠应讨论抗疟药的潜在获益与风险。
- 高剂量抗疟药在妊娠期应继续避免使用。
核心结论
- 儿童产前暴露适当剂量抗疟药后眼部毒性风险似乎低至不存在。
研究设计与样本
- 系统综述检索PubMed、Embase和Web of Science从建库至2017年3月的原始人类数据。
- 纳入10项队列研究、2项随机对照试验和3例病例报告,研究规模6至444名暴露婴儿。
主要发现
- 共研究1477名婴儿,其中789名暴露于羟氯喹或氯喹。
- 563名暴露婴儿有分娩后随访,随访范围从不足3个月至19年。
- 331名暴露婴儿在随访期间接受眼科检查。
临床怎么用
- 所有SLE妊娠应讨论抗疟药的潜在获益与风险。
- 妊娠期应继续避免高剂量抗疟药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether offspring from mothers with systemic lupus erythematosus (SLE), exposed in utero to antimalarials, have an increased risk of ocular anomalies during childhood versus unexposed SLE offspring. METHODS: We systematically performed searches of PubMed, Embase, and Web of Science databases for original human data on fetal and/or child ocular outcomes following exposure to antimalarials during pregnancy and/or lactation, from their inception until March 2017. RESULTS: A total of 10 cohort studies and 2 randomized controlled trials, ranging in size from 6 to 444 exposed infants studied, and 3 case reports met the inclusion criteria for our systematic review. Collectively, 1,477 infants were studied, 789 of which were exposed to hydroxychloroquine or chloroquine. In all, 563 exposed infants had follow-up visits after delivery (ranging from <3 months to 19 years), and 331 of these exposed infants underwent ophthalmologic examinations during the follow-up period. Our review of the literature suggests a low-to-nonexistent risk of visual abnormalities in offspring exposed to antimalarials. CONCLUSION: In children exposed to appropriate doses of antimalarials antenatally, the risk of ocular toxicity appears low to nonexistent. The potential benefits and risks of antimalarials should be discussed in all SLE pregnancies, and high dosages should continue to be avoided.
引用
- Gaffar R, Pineau CA, Bernatsky S, et al. Risk of Ocular Anomalies in Children Exposed In Utero to Antimalarials: A Systematic Literature Review. Arthritis Care Res (Hoboken). 2019. PMID: 30418703. doi:10.1002/acr.23808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。